Advertisement

Topics

Lixte Biotechnology Holdings Company Profile

10:55 EST 21st November 2017 | BioPortfolio


News Articles [437 Associated News Articles listed on BioPortfolio]

Lixte Biotechnology Holdings Inc LIXT Financial and Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125

Lixte Biotechnology Holdings Inc LIXT Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been com...

Lixte Biotechnology Holdings Inc LIXT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26102017] Prices from USD $250

SummaryLixte Biotechnology Holdings Inc Lixte is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and nonmalignant diseases. It develo...

Lixte Biotechnology Holdings Inc LIXT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryLixte Biotechnology Holdings Inc Lixte is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and nonmalignant diseases. It develo...

CTD Holdings Announces First Patient Dosed in Phase I/II Clinical Trial to Evaluate Trappsol® Cyclo™ in Niemann-Pick Disease Type C

ALACHUA, FL -- (Marketwired) -- 07/19/17 -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing cyclodextrin-based products for the treatment of disease, today announce...

CTD Holdings starts enrolment in Phase I/II trial of Trappsol Cyclo for NPC

US-based biotechnology firm CTD Holdings has started patient enrolment in the Phase I/II clinical trial of Trappsol Cyclo to treat patients suffering from Niemann-Pick disease type C (NPC) in Europe.

Abbey+ secures grant funding for Arcis Biotechnology Holdings Limited from Innovate UK

Abbey+ secures £110,000 worth of grant funding for Daresbury-based Arcis Biotechnology Holdings Limited from Innovate UK. An exciting new project will lead to new RNA diagnosticsRNA has huge pot...

Brain Ischemia Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Brain Ischemia Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Brain Ischemia. The key objective of the report is to establish the und...

Comparing Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings and Mylan N.V. are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst reco...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes.Primary infection is manifested as varicella (chickenpox), whereas reactivation of latent VZV resu...

Companies [1264 Associated Companies listed on BioPortfolio]

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular ...

Lixte Biotechnology Holdings

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Celtic Pharma Holdings Advisors LLP

Celtic Pharma Holdings Advisors is a global private equity fund management partnership focused on the biotechnology and pharmaceutical industries. Our second fund, Celtic Pharma Holdings II LP, in...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

More Information about "Lixte Biotechnology Holdings" on BioPortfolio

We have published hundreds of Lixte Biotechnology Holdings news stories on BioPortfolio along with dozens of Lixte Biotechnology Holdings Clinical Trials and PubMed Articles about Lixte Biotechnology Holdings for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lixte Biotechnology Holdings Companies in our database. You can also find out about relevant Lixte Biotechnology Holdings Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record